
|Videos|April 7, 2021
Dr. Matthew C. Ward on adjuvant radiotherapy in prostate cancer
Author(s)Urology Times staff
Ward's analysis includes a discussion of adjuvant radiotherapy versus early salvage radiotherapy.
Advertisement
Matthew C. Ward, MD, a radiation oncologist with the Southeast Radiation Oncology Group, discusses the use of adjuvant radiation in prostate cancer, including a comparison of adjuvant radiotherapy and early salvage radiotherapy.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
2
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
3
Choosing salvage therapy after prostate cancer focal ablation
4
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
5

















